Coinbase Prime announced yesterday that the company has established a collaboration with Enfusion to offer seamless crypto trading to institutional investors. The integration, which is expected to be completed during the second quarter of 2022 (Q2 2022), will give institutions easy access to the growing market of digital assets.

Coinbase Prime expects leading financial institutions to increase their crypto exposure in the future. The company aims to provide efficient institutional-level crypto services to its clients through the integration of innovative technologies.

“Enfusion’s connectivity with Coinbase Prime will allow us to seamlessly manage our crypto positions alongside other assets from a single interface, streamlining our trading operations. We’re very excited to see two platforms. We rely on the everyday team up to continue improving how institutions access the crypto markets," said Eric Peters, the CEO and CIO of One River, a leading asset management firm.

In September 2021, Coinbase Prime announced the launch of innovative features to help clients in the management of their portfolios. Earlier this year, Coinbase acquired Routefire to expand Prime Brokerage execution.

OEMS Enfusion

According to Brett Tejpaul, the Head of Institutional Sales, Trading and Prime at Coinbase, the institutional interest in digital assets has increased substantially in the last 12 months.

“By providing straight-through processing to Coinbase Prime via APIs, Enfusion is providing its clients institutional access to digital asset custody and algorithmic trading, with the potential to further our relationship in the future,” he said in a recent post.

“We’re excited to connect to our first OEMS Enfusion, as their native multi-asset management system is a natural first choice to collaborate with on a joint institutional offering. We expect financial institutions to continue to increase their portfolio exposure to crypto, and we’re committed to offering the best tools to enable them to manage it efficiently,” Tejpaul added.

Coinbase Prime announced yesterday that the company has established a collaboration with Enfusion to offer seamless crypto trading to institutional investors. The integration, which is expected to be completed during the second quarter of 2022 (Q2 2022), will give institutions easy access to the growing market of digital assets.

Coinbase Prime expects leading financial institutions to increase their crypto exposure in the future. The company aims to provide efficient institutional-level crypto services to its clients through the integration of innovative technologies.

“Enfusion’s connectivity with Coinbase Prime will allow us to seamlessly manage our crypto positions alongside other assets from a single interface, streamlining our trading operations. We’re very excited to see two platforms. We rely on the everyday team up to continue improving how institutions access the crypto markets," said Eric Peters, the CEO and CIO of One River, a leading asset management firm.

In September 2021, Coinbase Prime announced the launch of innovative features to help clients in the management of their portfolios. Earlier this year, Coinbase acquired Routefire to expand Prime Brokerage execution.

OEMS Enfusion

According to Brett Tejpaul, the Head of Institutional Sales, Trading and Prime at Coinbase, the institutional interest in digital assets has increased substantially in the last 12 months.

“By providing straight-through processing to Coinbase Prime via APIs, Enfusion is providing its clients institutional access to digital asset custody and algorithmic trading, with the potential to further our relationship in the future,” he said in a recent post.

“We’re excited to connect to our first OEMS Enfusion, as their native multi-asset management system is a natural first choice to collaborate with on a joint institutional offering. We expect financial institutions to continue to increase their portfolio exposure to crypto, and we’re committed to offering the best tools to enable them to manage it efficiently,” Tejpaul added.